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Abstract

MOLECULAR MECHANISMS OF CYTOKINE PRODUCTION BY
HUMAN LUNG FIBROBLASTS IN RESPONSE TO PSEUDOMONAS
AERUGINOSA ELASTASE
Kourtney Bass, BSC
Thesis Chair: Ali Azghani, Ph.D.
The University of Texas at Tyler
May 2015
Pathogenicity of Pseudomonas aeruginosa infections can be heavily influenced
by the host inflammatory responses. P. aeruginosa secretes several extracellular products
such as lipopolysaccharide, exotoxin A, and elastase. This bacterium is widely studied in
acute and chronic lung diseases, such as chronic obstructive pulmonary disease (COPD)
and Cystic Fibrosis (CF). In order to understand part of the underlying mechanism, we
focused on the role of Pseudomonas aeruginosa elastase (PE) in provoking the host
inflammatory response in an in vitro model. We hypothesized that PE stimulates cytokine
and chemokine production by activating mitogen activated protein kinase (MAPK)
cascade through nuclear factor kappa B (NFkB). We used biochemical, as well as

vi

immunological techniques, to confirm or reject our hypothesis. We found that PE
provokes the fibroblast through the epidermal growth factor receptor (EGFR) which leads
to the activation of the extracellular signal-regulated kinase (ERK) arm of the MAPK and
translocation of NFkB to the nucleus. Our data indicate that PE stimulates gene and
protein expression of the proinflammatory cytokine interleukin 8 (IL-8) through the
MAPK pathway. Furthermore, the use of specific inhibitors of EGFR, MEK, and NFkB,
AG 1478, U0126, and BAY 11-7085 respectively, confirmed the hypothesis. The study
confirms the importance of PE in P. aeruginosa induced infection and inflammation in
the human lungs.
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Chapter One
Introduction
Overview of the Project
Microbial infections are prominent throughout the world and demand continuous
investigation into the pathology of bacterial, viral, fungal and parasitic infections.
Pathogens can have a significant impact on the lifespan of humans by invading and
potentially destroying healthy organ systems (Li et al., 2012). Therefore, the number of
infections must be limited and therapeutic modality must be improved to decrease
infection related mortality and morbidity worldwide. A particular case of interest in
regards to pulmonary infections is Cystic Fibrosis (CF), where detrimental effects occur
from not only a genetic defect, but with recurrent microbial infections (Ratjen et al.,
2009). Unfortunately, the most common cause of death in CF population is respiratory
failure as a result of recurrent pulmonary infection and inflammation (Scheid et al., 2001;
Hogardt & Hessemann, 2013). Similarly, acute nosocomial, as well as community
pneumonias, among immunocompromised population are challenging health issues
(Camps Serra et al., 2008).
Cystic Fibrosis is the most common fatal autosomal, recessive disease in the
United States (Eidelman et al., 2001; Ren, L., 2008). Mutation in cystic fibrosis
transmembrane conductance regulator gene (CFTR) and defective CFTR ion channel are
the culprit gene and protein in CF disorder. The mutation causes an abnormal
1

physiological environment including thick mucus and low level of extracellular
glutathione (Griese et al., 2004). These change the molecular pathology of the cells which
leads to a greater sensitivity to reactive oxygen species (ROS) and increased
proinflammatory chemokines and cytokines including interleukin (IL) 8 because of
activation of signal transduction pathways such as mitogen activated protein kinase
(MAPK) (Pongnimitprasert et al., 2008). At the organismal level, these changes
compromise the ability of an individual to clear pulmonary infections among other health
issues (Roussel et al., 2011; Scheid et al., 2001). Establishment of a proinflammatory
environment as a possible sequelae of CFTR defect or response to microbial infections, is
suggested to play a significant role in further injury and remodeling of the lungs (Dalton
et al., 2012). The combination of compromised nutrient absorption and pulmonary
functions due to recurrent infections and inflammation increases the morbidity and
mortality in the CF population (Eidelman et al., 2001; Azghani et al., 2002).
The lung environment requires persistent flora flow just like any other system of
the human body. Normal fluid movement, cytokines and chemokines secretion and
ciliary motion are necessary components to maintain homeostasis in the lungs (Livraghi
& Randell, 2007). Mutation in CFTR, changes in mucus composition and the defect in
epithelial ciliary function creates a niche for opportunistic microbes such as
Staphylococcus aureus, Hemophilus influenza, and Pseudomonas aeruginosa in the lungs
(Govan & Nelson, 1992).
The purpose of this study was to investigate the role of elastase from
Pseudomonas aeruginosa. In the pathogenesis of Cystic Fibrosis, we studied the role of
bacterial elastase in inflammatory response of the structural cells of the lungs.
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Pseudomonas aeruginosa
Pseudomonas aeruginosa (PA), a Gram-negative bacillus, is an opportunistic
pathogen that causes necrotizing inflammation and systemic infections in
immunocompromised individuals with high mortality (Galle et al., 2008). The organism
causes acute nosocomial pneumonia as well as chronic pulmonary infection in CF. The
primary target of PA is immunocompromised patients, including individuals affected by
chronic obstructive pulmonary disease (COPD) and CF (Azghani et al., 2002; Qin et al.,
2012). Several antibiotics including macrolides and beta lactams are available to treat
pseudomonal infections effectively, but multidrug resistant PA in the CF community as
well as in a hospital setting is on the rise (Smith et al., 2001; Alvarez et al., 2010).
Most of the chronic PA infections are biofilm associated which leads to
interrogation of the affected tissue from the numerous counts of PA. Biofilms are
structured communities of bacterial cells enclosed in an extracellular polymeric matrix
consisting of secreted proteins, exopolysaccarides and nucleic acids, whichcan adhere
both to abiotic and biotic surfaces, serving as a permanent source of infections (Lima et
al., 2011). These modes of growth by pathogenic bacteria allow microbes to proliferate
even in the most hostile environments, including anaerobic environments and in CF
patients’ lungs where the supply of oxygen is lower (King et al., 2010). The biofilm
community causes chronic endobronchiolitis, is resistant to the innate immune defense,
and resists antibiotic therapy as well (Hoiby et al., 2001). P. aeruginosa is considered as
a well-rounded organism that thrives in a hostile environment, uncommon to some
typical bacteria that provoke human immune responses (Costerton et al., 1999).
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In addition to exploiting factors that limit the efficacy of the host immune
responses, PA has developed several mechanisms to escape the host innate and adaptive
immune responses. The formation of impenetrable biofilms, the intrinsic ability to
develop resistance to antibiotics, and the release of a large number of virulence factors
(e.g. lipopolysaccharide (LPS), exotoxins, and proteases) are included in PA arsenals
(Delden & Iglewski, 1998; Clark et al., 2011). An understanding of cellular signaling
events of the host in response to bacterial metabolites may have a profound effect in
discovering novel therapeutic modality.
The infection process for PA is similar to many other host-pathogen interaction.
The intrinsic bacterium first colonizes disrupted epithelium of the host organ system,
such as the lung tissue of a CF individual. After bacterial colonization and failure of the
innate immune system to overcome the pathogen, an acute infection arises (Delden &
Iglewski, 1998). In the acute phase, PA first colonizes the tissue at the beginning of the
invasion, where biofilms could be seen as well. The secretion of extracellular virulence
factors by the bacterium in the infection scenario causes extensive tissue damage,
bloodstream invasion, and bacterial dissemination to distant tissues (Delden & Iglewski,
1998; Pressler et al., 2011). P. aeruginosa initiates the onset of the not only acute
infection, but the recurrent chronic infection seen in CF patients because current therapy
is unable to eradicate PA infection (Qin et al., 2012).
As stated earlier and depicted in Figure 1, P. aeruginosa strains produce several
extracellular toxins and proteases that contribute towards its virulence (Wretlind &
Paviovskis, 1983). Lipopolysaccharide is one of the strongest virulence factors, which
induces the expression of certain chemoattractants (including IL-8), by immune cells,
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epithelial, and possibly some interstitial cells, therefore leading to neutrophils recruitment
to the site of infection (Figure 1; Kon et al., 1999).

Figure 1. Virulence factors of Pseudomonas aeruginosa. This bacterium has both cellassociated (flagellum, pilus, nonpilus adhesins, alginate, lipopolysaccharide, and extracellular
virulence factors (including proteases, hemolysins, exotoxin A, exoenzyme S, and pyocyanin)
(Adopted from Deldon, 1998).

It has been recognized that PA provokes the strongest inflammatory response in the
respiratory track which sometimes leads to septic shock or necrotizing (Kon et al., 1999).
We sought to investigate the potential role of Psuedomonas elastase and the interstitial
cells of the lungs in induction of the profound inflammatory response in PA pulmonary
infection and inflammation.

Characteristics of Pseudomonas aeruginosa elastase
P. aeruginosa produces three proteases, protease I (Las A), elastase (Las B), and
alkaline protease (protease III) (Wretlind & Paviovskis, 1983). The metalloproteinase
elastase (PE), produced as a cell wall-associated, inactive proenzyme, is one of the
5

strongest virulence factors produced by PA (Wretlind & Paviovskis, 1983; Kon et al.,
1999). Being a metal chelator-sensitive neutral proteinase that contains zinc, PE is active
against casein, elastin, hemoglobin, fibrinogen, and other proteins in neutral pH
environments such as the lungs and in vitro (Wretlind & Paviovskis, 1983; Clark et al.,
2011).
Pseudomonas elastase is capable of degrading various plasma proteins involved in
host innate immune system (Kon et al., 1999). Inactivation of complement factors
including C1, C3, C5, C8, and C9 by PE has been reported as well (Wretlind &
Paviovskis, 1983). This particular host defense tags invading pathogens for destruction,
and when PE inhibits the process, the host loses its ability to develop specific adaptive
immune responses.
PE causes leukocyte accumulation and increased vascular permeability which
leads to severe and damaging inflammation at the site of infection (Cohen & Prince,
2013). Therefore, identification of host cell receptors and PE-induced downstream
signaling pathways in the lungs parenchymal and stromal cells are essential steps in
understanding the pathogenesis of PA-induced lung injury and therapy.

Human Lung Fibroblast
The human pulmonary system is a multi-facetted collaboration of many cells
including epithelial cells and fibroblasts. The lung fibroblasts play a major role in tissue
repair by proliferating and secreting extracellular matrix components in the lungs’
parenchyma (Noordhoek et al., 2003). The remodeling of damaged tissue is primarily
dependent on the ability of the lung fibroblast to degrade the damaged extracellular
matrix components and replace them with the new and functional matrices (Kaufman et
6

al., 2001). Extracellular matrix elements have been an extreme concern in
embryogenesis, wound healing, and fibro-proliferative responses to tissue injury due to
infection and inflammation (Zhao, 1999). Alteration in fibroblast repair processes can
lead to extensive scarring, loss of utilities, and compromised pulmonary functions, which
lead to further investigation relative to their immunomodulary action (Kaufman et al.,
2001).
In response to bacterial infections, fibroblasts produce proinflammatory
cytokines and chemokines including IL-8 (Bedke et al., 2009). Similar to macrophages,
the fibroblasts are activated through a specific receptor, which activates intracellular
signaling cascades and cytokines’ gene expression and protein synthesis and secretion
(Glaros et al., 2009). The transcription factor nuclear factor kappa B (NFkB) has been
found to transcribe particular proinflammatory cytokine genes in response to pathogens,
but little is known about its effects in lung fibroblasts’ cytokine production (Kaufman et
al., 2001; Barnes, 2009). Therefore, we explored the effect of PE on NFkB activation in
human lung fibroblasts in vitro, along the hypothesized signaling route described below.
Several extracellular receptors provoke host intracellular signaling to regulate
particular gene transcriptions. The gene of interest could be for cytokine expression in
response to microbes or allergens or it may be essential for carrying on a homestatic
cellular function. Majority of human cells, including fibroblasts, express epidermal
growth factor receptor (EGFR) which is stimulated by growth factors including its
specific ligand the epidermal growth factor (EGF) (Mitsudomi & Yatabe, 2010). Once
activated, the EGFR signals the intracellular kinases such as the mitogen activated
protein kinase (MAPK) intermediates involved in cellular growth and differentiation
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(Robinson and Cobb, 1997; Yarden, 2001). Pseudomonas elastase activates cytokines
gene expression in epithelial cells as reported by Azghani et al (2002); however, the
mechanism of action of PE-induced IL-8 gene expression is not known at this time. The
recent discoveries have led us to examine PE/EGFR activation of MAPK signaling
cascade in human lung fibroblasts.

Process of Inflammation
As part of the innate immune system, inflammation consists of an elaborate
collaboration of cellular and chemical responses. The leukocytes, lymphocytes,
macrophages, dendritic cells, mast cells, as well as structural cells within tissue(s) play a
role in an effective immune response. Pathogens, including bacteria, viruses, fungi and
parasites, are able to set off the host immune signals and once initiated, inflammation
begins with local erythema, edema and pain. Inflammation is a phenomenal process in
the aid to clear an infection; however, hyperactivation of the system could cause tissue
destruction. For example, high neutrophil accumulation can cause host tissue destruction
observed in acute lung injury (Smith et al., 1997; Guo & Ward, 2002). Cytokine and
chemokine secretion by lung epithelia and fibroblast has also been reported with potential
benefit and harm, including a compromise in the metabolism of extracellular matrix
components (Wang et al., 2007).
The lungs of CF patients are prone to microbial infection, PA in particular,
because of the mutation in CFTR gene and dysfunctional CFTR ion channels.
Consequently, the CF lungs integrity is lessoned with recurrent infections and persistent
inflammation. The inflammation in the host can be determined by chemical markers, such
as cytokines and an increase in vascular permeability is instigated by infiltration of
8

proinflammatory cytokines and onset of inflammation and edema (Barnes, 2009).
Pseudomonas aeruginosa elastase has been found to be present in the lungs of infected
cystic fibrosis (CF) individuals and more than likely affects their inflammatory responses
(Azghani et al., 2002; Delden & Iglewski, 1998). Since PA infections of CF patients
comes with high morbidity and mortality, understanding the mechanisms of PE induced
inflammatory responses and the pathogenesis of the lung injury, due to PE, will aid in
determining therapies for PA infection within immunocompromised individuals and the
CF population.

Mediators of Inflammatory Response
Cytokines are mediators that are characterized as low molecular weight proteins
that are expressed upon cell activation by stimuli. Derived from the Greek root “to set in
motion”, cytokines use specific cell receptors and intercellular signaling mediators of the
effector cells in the endocrine, autocrine, and paracrine range (Sherry and Cerami, 1988).
More than 80 peptide members exist within the cytokine family that are released from
microbe-stimulated leukocytes or structural cell (Cannon, 2000). Along with their Greek
terminology, cytokines can be considered for their unique name because nearly all
eukaryotic cells have the potential of producing these proteins as well as responding to
them (Dinarello, 2000). In addition to their role in infection and inflammation, cytokines
are involved in a variety of cellular functions including proliferation and differentiation
(Liao et al., 2011). Cytokines have been classified based of their receptors, therefore
leading to the assorted nomenclature such as hematopoietic growth factors, chemokines,
and interleukins (Oppenheim, 2001; Liles & Voorhis, 1995). Interleukins (ILs) are
produced by host immunological aids, such as macrophages, monocytes, and some tissue
9

cells, and bind to specific receptors and are involved in inter-cellular communication in
the immune system in response to extracellular stimuli (Akdis et al., 2011; Rainsford et
al., 1996). Chemokines, on the other hand, act as stimulators or inhibitors of
inflammation by recruiting or inhibiting of specific populations of leukocytes to the site
(Gouwy et al., 2005; Smith et al., 1997). Several of the proinflammatory cytokines,
and/or chemokines, accumulate in the airways of patients with acute and chronic
pulmonary diseases and when infection occurs (Teijaro et al., 2011; Hartl et al., 2007;
Guo and Ward, 2002). Microbial toxins and metabolites commence gene expression by
the host in an effort to initiate an array of inflammatory responses through signaling
molecules (Gouwy et al., 2005). Cytokines and chemokines both initiate the recruitment
and retention of bone marrow-derived immune effector cells such, as T-cells and B-cells.
A sustained accumulation of neutrophils in the airways of individuals with chronic lung
diseases is an inflammatory response observed when microbe-induced IL-8 secretions
occur (Hartl et al., 2007; Kaufman et al., 2001; Roussel et al., 2011). It has been noted
that high accumulation of IL-8 is associated with the chronic inflammation seen in CF
patients (Smith et al., 1997). Since sub-epithelial fibroblasts are continuously exposed to
microbial products released in the lumen of the airways, understanding the consequence
of the fibroblast activation and their effector molecules will provide an effective
treatment modality in pulmonary infection and inflammation (Scheid et al., 2001).
Inflammation can be a response to specific proinflammatory cytokines and/or
chemokines stimuli that trigger an initial molecular signaling event. The gene for IL-8, a
highly recognized cytokine in immune response, is transcribed by several transcription
factors including a commonly observed factor known as nuclear factor kappa B (NFkB)
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(Roussel et al., 2011; Akdis et al., 2011). Recent studies indicate that the cells of nonblood origin, including fibroblasts, can also secrete this prominent cytokines (Dinarello,
2000). In CF studies, IL-8 plays a crucial role in the inflammation of the lungs as well as
tissue destruction because of the continual recruitment and activation of immune effector
cells and neutrophils in particular (Cohen & Prince, 2012). Since the fibroblasts are the
chief producer of extracellular matrix components necessary for cell migration and tissue
remodeling, they may lag in making the necessary materials to rebuild the impaired tissue
while assisting to resolve an infection (Wang et al., 2007). Though the cells of blood
origin are primarily recognized as the IL-8 source, the mechanism, magnitude, and
consequence of the contribution of structural cells, such as fibroblasts, to the
inflammatory process is not yet clear (Akdis et al., 2011). Studies have shown that the
transcription of IL-8 depends on specific stimuli, host cells’ extracellular receptor, cell
type, and possibly all three variables combined (Groessl et al., 2012). For instance,
lipopolysaccharide utilizes the toll-like receptor 4 (TLR4) on the human lung fibroblast to
provoke an inflammatory response to Gram-negative bacteria (Zhang et al., 2011). Also,
the CD40 transmembrane domain of fibroblasts is known as a crucial element in the
process of fibroblast activation and cytokine and chemokine production (Kaufman et al.,
2001). Investigation into novel fibroblast receptors and their downstream signaling
related to immune response are cellular events that need further investigation.
In addition to IL-8, other proinflammatory cytokines and chemokines are
responsible for tissue destruction at the site of infection. Interleukin 1 Beta (IL-1ß) is a
common proinflammatory cytokine produced by several immune cells including resident
macrophages (Akdis et al., 2011). Interleukin 1ß plays an important role in the
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coordination of local and systemic inflammation by inducing the expression of other
proinflammatory cytokines such as IL-6 (Akdis et al., 2011). Tumor necrosis factor alpha
(TNFα) is another proinflammatory cytokine with a conserved genetic sequences in
several cell types (Akdis et al., 2011). This cytokine, combined with other immune
mediators, produces a local state of inflammation to aid the eradication of an invading
pathogen(s) (Parham & Janeway, 2009). Tumor necrosis factor alpha (TNFα) is
primarily released by macrophages, as a result of toll-like receptors stimulation by
bacterial products including LPS and DNA and later needs to be explored in other
reactions (Parham & Janeway, 2009). Regulation of immune effector molecules and cells
during inflammatory response in vitro have been seen to be interrupted in the presence of
P. aeruginosa (Azghani et al., 2002). This study will seek to identify the mechanism of a
bacterial stimuli to potentially provoke an inflammatory response in a lung structural cell
through the observance of cytokine secretion.

Epidermal Growth Factor Receptor (EGFR) and Inflammatory Response
Eukaryotic cell response to extracellular stimuli by means of cellular receptors
and consequent intracellular signaling pathways propagate gene activation (Robinson &
Cobb, 1997). These genetic responses may include cell growth and differentiation,
cellular repair, induction of inflammation, and destruction of the pathogen (Mutalik &
Venkatesh, 2006).
The tyrosine-kinase epidermal growth factor receptor (EGFR), a member of the
ErbB family receptors, is a multi-function receptor that regulates key cellular processes
such as proliferation, survival, and differentiation during development and potentially
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inflammation (Pastore et al., 2007; Schneider & Wolf, 2009). Ligation of the EGFR by
extracellular stimuli initiates activation of downstream signaling pathways including
MAPK. Epidermal growth factor receptor can be activated by several extracellular
mediators including metalloproteinases from neutrophils, but whether or not bacterial
proteases, including elastase from P. aeruginosa, utilize this receptor to induce the host
inflammatory response is not yet clear (Pastore et al., 2007). This study investigated the
role of EGFR in PE-induced inflammatory response by the lung fibroblast.

Mitogen Activated Protein Kinase Pathway
The mitogen activated protein kinase pathway is a conserved cellular signaling
cascade in eukaryotes (Plotnikov et al., 2011). The pathway serves as a regulatory
element that mediates the transduction of signals from the cell surface to the nucleus
(Mutalik & Venkatesh, 2006; Robinson & Cobb, 1997). The MAPK cascade regulates
numerous cellular processes including cell differentiation, movement, division, and
apoptosis (Mutalik & Venkatesh, 2006). The MAPKs are grouped into subfamilies on the
basis of sequence similarity, mechanisms of upstream regulation, and sensitivity to
activation by different mitogen activated kinase kinases (MEKs) (Robinson & Cobb,
1997; Mutalik & Venkatesh, 2006). Multiple arms of the MAPK pathways, ERK,
JNK/SAPK, and p38, can be individually stimulated by the upstream signaling events
with different outcomes. For example, the p38 MAP kinase and the JNK/SAPKs are
recognized as stress sensors and sometimes can promote apoptosis (Goldsmith et al.,
2004). The extracellular signal-related kinase (ERK) arm of MAPK is involved in cell
growth, proliferation and differentiation (Napoli et al., 2012). Two proteins with
molecular weight of 42 KDs and 44 KDs known as ERK ½ are activated by MAPK
13

kinase known as MEK, which in turn is activated by a MEK kinase (MEKK) (Robinson
& Cobb, 1997). Phosphorylation of particular amino acids of ERK1/2 activates or
inhibits particular downstream mediators of the pathway to transcribe appropriate gene
expressions (Figure 2) (Mutalik & Venkatesh, 2006). Given the right stimuli, the EGFR
could activate upstream intermediate molecules of ERK, which in turn can cause
activation and translocation of NFkB into the nucleus for further gene expression
(Oekinghaus et al., 2011). PE might elicit this response; however, the mechanism of PEinduced EGFR activation and its outcome is not clear at this time (Azghani et al., 2002;
Azghani et al., 2014).

Figure 2. Schematic presentation of the RAF/ERK/MAPK signaling
pathway. (Kabarrah & Chin, 2006)

Nuclear Factor Kappa B
Numerous transcription factors (TFs) are triggered to initiate specific gene(s)
expression following ERK activation. The nuclear factor kappa B (NFkB) is a known TF
involved in inflammatory responses observed in in vitro and in acute lung injury models
14

(Chen et al., 2011; Azghani et al., 2002). Activation and translocation of NFkB to
nucleus occur in response to pathogens, including P. aeruginosa, and/or their virulence
factors including LPS (Roussel et al., 2011). Translocation of NFkB to the nucleus occurs
after phosphorylation of its bound inhibitor I-kappa B (IkB) and release of NFkB (Guma
et al., 2011). Once in the nucleus, NFkB transcribes specific genes including
proinflammatory and inflammatory chemokines and cytokines (Goh et al., 2012).
In addition to EGFR, microbial virulence factors ligate TLRs and activate specific
signaling cascades and promote gene expression. For instance, P. aeruginosa LPS
activates several cytokines’ gene expression and protein synthesis via
TLR4/MD2/CD14/MyD88 complex which may cause septic shock via NFkB induced
transcription of cytokines including tumor necrosis factor (TNF-α) and IL-6 (Paraham &
Janeway, 2009). Accordingly, we sought to observe NFkB’s involvement in the
fibroblasts’ inflammatory response to P. aeruginosa.

Objectives
The human population will continue to witness episodes of common, emerging,
and reemerging infectious diseases. With continual microbial infections occurring as
secondary complications in immunocompromised individuals, persistent research in
pathogen/host interaction is a necessity. An opportunistic-bacterial infection of soft
tissues and the human pulmonary system will be studied. In particular, we specifically
focused on the mechanism of the human lung fibroblast’s inflammatory response to
Pseudomonas aeruginosa elastase along a targeted, known signaling pathway. It is
hypothesized that PE provokes an inflammatory response along the MAPK signaling
route in the human lung fibroblast, measured by the secretions of IL-8 (Figure 3). At this
15

time, PE’s involvement in the highly utilized MAPK signaling event in other types of
cells or tissues is unclear. This study will give us more insight of Pseudomonas
aeruginosa’s mechanistic involvement in a normal host’s physiological environment and
raise awareness to undetermined events in an immunocompromised pulmonary system.

HLF
NFkB

PE
EGFR

Nucleus

ERK
MEK

Proinflammatory
cytokines

Figure 3. Hypothesized signal transduction pathway in the human
lung fibroblasts (HLF) for production of proinflammatory cytokines.
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Chapter Two
Material and Methods
Cell Culture
An established line of human lung cells, IMR-90, isolated from normal fetal lung
tissue were used at the fifth through the sixteenth passages. The cell line was obtained
from the American Type Culture Collection (ATCC Manassas, VA). The fibroblasts were
grown in Minimum Essential Medium (MEM Sigma-Aldrich St. Louis, MO)
supplemented with 1% nonessential amino acids, 10% fetal bovine serum (FBS Life
Technologies Grand Island, NY), 1% L-glutamine, 1% penicillin and streptomycin
antibiotics, and 2.5 μg/mL Plasmocin (Invivogen, San Diego, CA). The cells were
maintained in T25 cm2 and T75 cm2 cell culture flasks in the complete MEM medium
and kept in a humidified incubator at 37 °C in 5% CO2. Media were removed and
replaced every two days. The lung fibroblasts were transferred to new flasks and/or plates
when the cells formed confluent monolayers on the bottom of the flask.

Mediators and Treatment Modality
The fibroblasts were serum-starved for 18 hours prior to treatments. Cells were
treated with PA products, lipopolysaccharide (LPS) or elastase (PE) from P. aeruginosa,
for selected time periods and post-treatment sampling times. Purified PE was obtained
from Elastin Products Company (EPC, Owensville, MO). Lipopolysaccharide was
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purchased from Sigma-Aldrich Company and was used as a known positive control for
cell activation (Zhang et al., 2011; Azghani et al., 2002). TRIzol (Invitrogen, Grand
Island, NY) was used for nuclear extraction, ribonucleic acid (RNA), along with high
grade chloroform.
Three specific MAPK inhibitors were used to investigate the role of selected cell
signaling pathways. The MEK inhibitor U0126 was used to prevent MEK
phosphorylation. The inhibitor AG 1785 was used in order to block the EGFR, while
BAY 11708 was incorporated to prevent NFkB translocation to the nucleus. All
inhibitors were purchased from Calbiochem, Darmstadt, Germany. Pre-confluent cell
monolayers, grown in 24, 48, and 6-well cell culture plates were treated as described
(Table 1) and supernatants were collected and centrifuged to remove cell fragments and
were stored at -80 ̊ C for further analysis.
Table 1. Treatments and corresponding concentrations used. A (+) indicates the
positive controls within the design. Serum free Minimal Essential Media (MEM) alone
used as negative control. All treatments were diluted FBS-free MEM.

Treatment

Concentration

MEM-

Non-treated
media

PE

1.2 U/mL

LPS+

5 μg/mL

FBS+

20%

EGF+

1 μg/mL

U0126

10 μM

AG 1478

10 μM

BAY 11-7085

10 μM
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Total RNA Extraction
Fibroblasts grown in cell culture dishes, as described previously, were lysed with
TRIzol solution (Life Technologies Grand Island, NY) for total RNA extraction
according to an in-house laboratory protocol. After the completion of treatments, the
supernatant was removed from each cell culture dish and frozen until later protein
analysis. Next, 1 mL of TRIzol solution was added to each dish and incubated at room
temperature for 10 minutes. The solution of TRIzol and lysed cells’ content were
transferred to a 2.0 mL centrifuge tube where we added 0.3 mL of chloroform to each
1mL solution. Each vial was then agitated for 20 seconds and incubated at room
temperature for 10 minutes. Afterwards, each vial was centrifuged at 1400 rpm at 4°C for
15 minutes. The RNA separated into the top, aqueous phase (clear supernatant) where the
DNA and proteins settled at the interphase. The clear top layer was carefully removed
without breaking into the interphase and put the sample into a clean, autoclaved
centrifuge vial. 500 μL of isopropyl alcohol (500 μL per 1 mL of TRIzol used) was added
and each vial was agitated gently before the solution was stored in -20°C for 10 minutes
to aid in detecting the RNA isolate. Next, we centrifuged the alcohol mixture at 1400 rpm
for 15 minutes at 4°C and the RNA pellet formed at the tip of the vial was mixed with
1mL ethanol (1:3 parts DEPC autoclaved water to 75% ethanol). Centrifugation was
completed two more times to keep the RNA pellet whole and to separate the pellet from
the alcohol to allow faster drying. Lastly, the centrifuge vial cap was gently left open for
all alcohol to completely evaporate and leave behind the RNA. The RNA pellet was
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resuspended with 20 μL of preheated (60°C) RNA Secure and the sample was heated at
60°C for 10 minutes as suggested by the manufacturer.
The resuspended RNA was measured right away using a nanospectrophotometer
(Nanodrop 1000, Thermo Scientific Wilmington, DE)at the optical density (OD) of
261/280 nm. 2 μL of RNA sample to read the total RNA with 2 μL autoclaved DEPC
water flushes between each reading. For the OD ratio of 261/280, a reading of 1.8-2.2
was determined as a good RNA sample and a reading lower than the suggested range was
considered as having protein or DNA contamination.

Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR)
A high-capacity reverse transcription kit was used to convert extracted RNA
molecules to single-stranded DNA molecules (ssDNA or cDNA). This kit was purchased
from Applied Biosystems (Life Technologies Grand Island, NY) and protocol was
followed from manufacturer’s instructions.
For each run, 1μg of each treated sample was used to perform the reverse transcription
and then added to the RNA Secure and DEPC-treated water solution resulting in a final
volume of 5μL. Each reaction was kept at 37°C for 2 hours and afterwards immediately
set at 85°C to deactivate the transcriptase. All completed reactions were stored at -20°C
for future qRT-PCR assay.
A primer set of the target cytokine was used in order to detect the particular gene
expression. The forward and reverse primers for IL-8 were from Bioneer, Alameda, CA.
The primers were rehydrated to establish a 100 pmoles/μL concentration and stored at
-20°C until the assays were run.
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To establish a standard curve and positive controls for the PCR, we carried out a
serial dilution of the plasmid carrying the IL-8 gene and the housekeeping gene
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (primers: forward 5’TCGGAGTCAACGGATTTGGTCGTA, REVERSE
5’AGCCTTCCTCCATGGTGGTGGTGAAGA) was used as a regulatory control and
establishing a baseline for the test RNA molecules. Quantitative PCR of human IL-8 was
performed in triplicate. A 15 μL final volume of PCR mix containing 200 nM of each
forward 5’ TGCGCCAACACAGAAATTATTGTA and reverse 5’
ATTCTCAGCCCTCTTCAAAAACTT primer and 50 ng of cDNA in a master mix
(10 μL) containing 7.5 μL of 2 x iTaqSYBR Green Supermix with ROX (Bio-Rad
Hercules, CA) and 2.5 μL of the primer set at a final concentration of 0.05 μM for each
amplicon were added to the wells of a MicroAmp Fast 96-well reaction plate (Applied
Biosystems – Life Technologies). The plates were carefully sealed with optical adhesive
cover 4360954 (Applied Biosystems – Life Technologies Grand Island, NY) and placed
in a StepOnePlus real-time PCR system with data collection software v2.1 (Applied
Biosystems – Life Technologies Grand Island, NY). The expression of IL-8 in treatment
samples was compared to that of untreated control cells. Cycler setup was established
according to the iTaqSYBR Green Supermix with ROX manufacturer’s protocol.

Single-Analyte Enzyme-linked immunosorbent assay (ELISA)
The replaced media, or supernatants, from cell culture wells were used to quantify
secreted IL-8 protein after treatments. A 96-well plate was pre-coated with IL-8 capture
antibody (primary antibody) overnight. A wash buffer, consisting of 1x PBS and
Dulbecco buffered salts, was used as a wash solution between each step to rinse excess
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reagents from the treatment plate according to the manufacturer’s protocol (Biolegend
San Diego, CA). A protein blocking agent (assay diluent) was added to each well of the
96-well plate, and allowed to sit at room temperature in wells for one hour while rocking
at 200 rpm. The assay diluent was removed from the plate and another rinse with wash
buffer was applied. A standard curve was established by a 1:2 serial dilution of 1000
pg/mL of IL-8 protein as well. The sample supernatants were removed from frozen
storage and thawed in ice and spun in a microcentrifuge for 10 minutes at 1000 rpm and
22°C. Each sample was added to the well according to our design of the run and was
incubated for two hours while shaking at 200 rpm. The plate was washed with wash
buffer and the detection antibody (secondary antibody) was added to each well for one
hour while shaking at 200 rpm. Detection antibody was washed from the plate and
Avidin-HRP enzyme was added to sit in the wells for thirty minutes while rocked in the
dark. The Avidin-HRP leftover solution was washed with wash buffer and TMB
Substrate Solution was added for 15 minutes in the dark without shaking. A blue color in
the wells would appear with the addition of the substrate which turned stable yellow with
the addition of 2N H2SO4 solution. The plate was read with the Beckman Coulter AD 340
microplate reader at the OD=450 nm absorbance and subtracted from the data at OD=570
nm in order to eliminate the plastic plate absorption, if any. The data were normalized log
arithmetically by the AD 340 software and optical densities were translated into
concentrations of IL-8 in pg/mL.

Statistical Analysis
A one-way ANOVA and Dunnett’s post-test analysis were performed to test the
differences among the treatment groups in comparison with the control. Results are
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presented as means of at least three independent experiments. Standard errors were
calculated to observe the means of each treatment represented in an experiment and were
represented by error bars. P-values less than 0.05 were considered statistically significant
for the means of each treatment.
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Chapter Three
Results

Effect of P. aeruginosa elastase on Cytokine Production by Human Lung
Fibroblasts: Dose and Time Course Study
Different concentrations of enzymatically active and inactive PE were utilized in
order to determine the optimal PE concentration and exposure time in cytokine
production by IMR-90 monolayer in culture. Three different concentrations of PE were
used as suggested by previous studies in our laboratory which included 0.6 U/mL, 1.2
U/mL, and 2.0 U/mL. Based on the preliminary data, the 1.2 U/mL concentration was
found to be the optimal dose in this project.
As for the exposure time, based on previous signal transduction study reports
from our laboratory, we carried out PE exposure experiments at 10 and 20 minutes and
measured IL-8 protein expression at 6 and 24 hours post incubation (Azghani et al.,
2002). At the 10 minute treatment time, we found a significant increase in IL-8production
while doubling PE treatment time did not change the IL-8 production significantly
(Figure 4).
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Figure 4. IL-8 production at 24 hours post treatment with PE (1.2 U/mL). IMR-90
grown to confluence in culture plates produced more IL-8 when they were exposed to
PE for 10 minutes. Doubling exposure time did not affect the cell response. Error bars
represent the standard errors of the means. Asterisks indicate significant difference
between treated and control cells at p<0.05, n=3 independent experiments.

To determine whether enzymatic activity of PE is necessary PE-induced IL-8 expression,
we compared IL-8 protein expression by the monolayers exposed to active enzyme to that
of 1.2 U/mL of PE after heat-inactivation in a boiling water bath for 20 minutes. As
shown in Figure 5, results indicated that only the active form of elastase provoked the
lung fibroblasts to secrete IL-8 significantly. Based on these findings, we used
enzymatically active PE in preceding experiments.
Optimal post-treatment incubation times for cytokine production were evaluated
at 6 hours, 16 hours, and 24 hours after 10 minutes PE exposure and rinse. Cells in
culture plate were tested with different cell holding capacity and found that both a brief 6
hours as well as a 24 hours post-treatment periods were sufficient to statistically
differentiate the PE effect on IL-8 production by cultured IMR-90 monolayers. The 24
hours post-treatment time; however, was sufficient when cells were confluent in a 48well plate, while the 6 hours post-exposure time was suitable when more cells were
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grown in a 6-well plate. Thus in proceeding experiments, IL-8 protein secretions were

% Production IL-8

measured from treated confluent monolayers of IMR-90 cells grown in 48-well plates.

*

450
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200
150
100
50
0
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Active PE 10 Inactive PE
min
10 min
Treatments

Figure 5. Comparison of the effects of enzymatically active of PE to that of the heatinactivated protease on IL-8 production. Cells were treated with PE (active and inactive)
for 10 minutes, washed and left alone in MEM for 24 hours. Data indicate % increase in
IL-8 concentration in the supernatants. Error bars represent standard error of the means
(n=3 independent experiments). Asterisks indicate significant difference from the control
at p<0.05.

P. aeruginosa elastase Triggers IL-8 Gene Expression in the Human Lung
Fibroblast through EGFR/ERK 1/2 stimulation
In an effort to investigate the mechanism of action of PE-induced IL-8 secretion,
we hypothesized that PE activates IL-8 gene expression through EGFR/MAPK signaling
pathways in the lung fibroblast. Specific blockers were used in different stages of these
pathways to address the mechanism of action of PE-induced IL-8 gene expression. The
cells were exposed to PE in the absence and presence of specific EGFR and MAPK
signaling inhibitors outlined below. At the conclusion of each experiment, the cell lysates
were used to quantitate IL-8 gene expression using quantitative real time polymerase
chain reaction assays (QRT-PCR).
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To determine if IL-8 gene expression was dependent upon ERK1/2 activation, the
monolayers were pretreates with a MEK inhibitor (U0126, 10 µM, 15 min) prior to PE
treatment. As shown in Figure 6, pretreatment with specific MEK inhibitor completely
abrogated PE-induced IL-8 mRNA expression. Blocking EGFR activation by its specific
inhibitor AG 1478 (300 nM, 60 min) confirmed the involvement of EGFR in PE-induced
IL-8 mRNA expression (Figure 6). The relative expression of IL-8 mRNA was estimated
by quantitative real time polymerase chain reaction assays of the RNA samples isolated
from cells treated with PE or positive control EGF in the presence or absence of AG1478
pretreatment. The data shown in Figure 6 revealed that both PE and EGF caused
significant increase in IL-8 gene expression and the induction of IL-8 mRNA was
repressed by the signaling inhibitor in both instances. We should point out that the IL-8
mRNA expression for each treatment was presented as a ratio of the untreated control
(relative quantity control). The variance in RNA quantity was normalized by
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene expression.
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Treatments
Figure 6. PE-enhanced IL-8 mRNA expression is abrogated by inhibition of EGFR
activation. Confluent monolayers of IMR-90 cells grown in six-well plates were
serum starved overnight. The monolayers were then treated with PE (1.2 U/mL) or
EGF (1µg/mL) in the presence or absence of AG 1748 (10 µM). Monolayers treated
with the medium or AG 1478 alone were used as controls. At the end of 2 hours
treatment, total RNA was isolated and analyzed for IL-8 gene expression by QRTPCR analysis. The IL-8 mRNA expression for each treatment was presented as a ratio
of the untreated control (relative quantity control). The variance in RNA quantity was
normalized by GAPDH gene expression. Asterisks indicate significant difference
from the control at p<0.05.

Effect of EGFR/ERK/NFkB Activation on IL-8 Protein Secretion by the
Human Lung Fibroblast from PE exposure
We next sought to determine the influence of EGFR/ ERK/NFkB signaling
pathways on IL-8 protein production and secretion by cultured lung fibroblasts. The
supernatants from MEM (negative control), FBS and LPS (positive controls) and PE (1.2
U/mL, 10 min)-treated cells were analyzed for IL-8 protein content. PE enhanced IL-8
protein secretion in an amount comparable to that of P. aeruginosa LPS, a well-known
activator of IL-8 expression (Figure 7, LPS and PE). The concentration of IL-8 secreted
in the medium was significantly (p<0.05) higher with PE or LPS treatment compared to
the control. The MEK inhibitor U0126 blocked PE-induced IL-8 production (Figure 7,
U0126 + PE). The influence of PE on IL-8 production by fibroblasts in the presence of
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specific inhibitors of EGFR (10 µM, 15 min), and NFkB (BAY 11-7085, 10 µM, 15 min)
are shown in Fig. 7 as well. All above-mentioned inhibitors suppressed IL-8 production
significantly (p<0.05), suggesting a link between PE-induced activation of EGFR with
MAPK and NFkB signaling pathways leading to de novo synthesis and secretion of IL-8.
The data depicted in Figure 8 confirm the notion that PE activates EGFR
signaling evens in a manner similar to that of its specific ligand EGF. Just like PE, EGF
utilizes EGFR/ERK/NFkB signaling mediators to increase IL-8 protein secretion in
human lung fibroblasts. Specific inhibitors of the aforementioned pathways reduced IL-8
production to the lever of MEM-treated control cells (Figure 8, U0126+EGF,
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Figure 7. PE-induced IL-8protein
secretions in the presence and absence of
specific signal transduction inhibitors;
U0126 inhibits MEK, AG1478 inhibits
EGFR ligation, and BAY11-7085
inhibits NFkB translocation. Error bars
represent the standard error of the means
(n=3 independent experiments, p<0.05).
Asterisks indicate groups statistically
different from the control group.

29

Figure 8. EGF-induced IL-8protein
secretions in the presence and absence of
specific signal transduction inhibitors (a
known induction used as our positive
control); U0126 inhibits MEK, AG1478
inhibits EGFR ligation, and BAY117085 inhibits NFkB translocation. Error
bars represent the standard error of the
means (n=3 independent experiments,
p<0.05). Asterisks indicate groups
statistically different from the control
group.

Chapter 4
Discussion

Determining the effector molecules in host-pathogen interaction in acute and
chronic infections could be the key to understanding underlying mechanisms of disease.
The opportunistic human pathogen, P. aeruginosa (PA), causes nosocomial pneumonia
and recurrent pulmonary infection in individuals with hereditary CF disease (Murray et
al., 2007). Build-up of a dehydrated mucus in an environment and accumulation of
activated as well as dead immune cells, provides a suitable microbial growth medium
(Bharnsholt et al., 2009). P. aeruginosa’s ability to thrive in such an environment for the
rest of the host’s life cycle will depend on several virulence factors including elastase, the
protease of interest in this project.
Virulence factors are bacterial weapons to resist host innate and adaptive immune
responses. P. aeruginosa elastase is a well-known virulence factor that is implicated in
pathogenesis Pseudomonas-induced injury in individual affected by CF (Delden &
Iglewski, 1998; Pressler et al., 2011). Pulmonary epithelia is the first line of defense in
the fight against bacterial infection and invasion. In the case that epithelial are impaired,
bacteria will disseminate to the lungs parenchyma as well as stroma, and the blood stream
(Smith et al., 1996; Parsons et al., 1987; Azghani et al., 1990; Rejman et al., 2007).
Likewise, the lung fibroblasts are important in the system’s homeostasis, support
of epithelia, and parenchymal tissue reconstruction. Furthermore, fibroblasts’ role in local
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immune defense is now appreciated through production of the proinflammatory
chemokine IL-8 (Noordhoek et al., 2003; Bedke et al., 2009). An initial, external stimulus
is needed to prompt cytokine production by the fibroblast in their efforts to recruit the
effector cells of the immune system. Lipopolysaccharide of P. aeruginosa is a wellknown stimulus of such a response (Kon et al., 1999). Previously published reports and
the data reported here indicate that PE is a potent immune response activator as well. The
mechanism of action of PE-induced immune response in structural cells of the lungs are
not yet clear.
Eukaryotic cells respond to extracellular stimuli by means of cellular receptors
and activation of downstream signal transduction pathway(s), which results in specific
gene expression (Robinson & Cobb, 1997). The MAPK pathway is a conserved signaling
cascade that mediates the transduction of signals from the cell surface to the nucleus
(Plotnikov et al., 2011; Mutalik & Venkatesh, 2006; Robinson & Cobb, 1997). The
MAPK is composed of multiple arms, ERK1/2/JNK, and p38, which are involved in cell
proliferation and differentiation, and the transcription factor NFkB is observed as the
transcription factor for many of these cellular mechanisms (Napoli et al., 2012; Chen et
al., 2011; Nasu et al., 2007; Azghani et al., 2002).
Activation and translocation of NFkB to the nucleus occur in response to
pathogens, including P. aeruginosa, and its LPS (Roussel et al., 2011; Akdis et al., 2011).
Elastase from PA also induces NFkB activation and IL-8 gene expression and propose
that the pathway is activated by upstream signaling events involving EGFR and MAKP
(ERK1/2). Several extracellular stimuli activate the MAPK cascade and can thereby elicit
a wide range of responses dependent upon the properties of the target cells (Cobb, 1999;
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Kumasaka et al., 1996; Rosenfeld et al., 2001). In inflammation, activation of the
ERK/MAPK in host cells stimulates transcription of several cytokine genes through
activation of nuclear transcription factors such as NFkB (Blackwell et al., 2001; Li et al.,
1998; Pendurthi et al., 2000). In the cultured human lung fibroblasts utilized in this
study, PE likewise enhances IL-8 gene expression by activation of NFkB. However, the
involvement of other transcription factors in PE-induced IL-8 gene expression remains
probable and requires further exploration.
Fibroblasts comprise over 40% of the parenchymal cells in human lungs and their
role in maintenance of the structural integrity and function of the lungs has been
confirmed by several investigators (Behzad et al, 1996; Dulon et al., 2005). Induction of
chemokine secretion by lung fibroblasts may contribute to the migration of leukocytes
into the parenchyma of the injured lung (Dulon et al., 2005). Under normal conditions,
the intact respiratory epithelial lining sequesters lung fibroblasts from direct exposure to
bacterial cells or their metabolic products (Gauldi et al., 1992). In respiratory infections, a
breach in the epithelial lining occurs under the influence of host factors and bacterial
products, allowing bacteria and their toxins access to submucosal and interstitial lung
fibroblasts (Azghani et al., 1990; Pearson, et al., 2000; Poynter et al., 2003). PE is one
such bacterial product that can disrupt the epithelial lining and may contribute to
pathogenesis of Pseudomonas infection (Azghani, 1996; Azghani et al., 2000; Donald et
al., 1982).
High concentrations of IL-8 in the lungs have been linked to the pathogenesis of
CF as well as acute pulmonary diseases including the acute or adult respiratory distress
syndrome (ARDS) and sepsis (Armstrong et al., 1997; Meyer-Hoffert et al., 2004). In
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animal models of P. aeruginosa lung infections, a marked polymorphonuclear neutrophil
(PMN) infiltration that appears to be due to IL-8 production from lung fibroblasts,
epithelial cells, as well as macrophages (Blackwell & Christman, 1996; DiCamillo et al.,
2002; Tang et al., 1993). Several bacterial metabolites including LPS, elastase,
autoinducer N-3- Oxododecanoyl homoserine lactone, pyocyanin, as well as flagella and
pili stimulate respiratory epithelial cells to produce IL-8 (Azghani et al., 2000; Noah et
al., 1997; Smith et al., 2001). However, the effects of PE on expression of IL-8 by lung
fibroblasts is poorly understood, a gap in current knowledge that is addressed by the
observations reported herein.
P. aeruginosa elastase enhances IL-8 production in human lung fibroblasts in
culture, is in part, via activation of the ERK1/2 arm of MAPK pathway and activation of
NFkB. These data confirm the role of PE in pathogenesis of pulmonary inflammation and
reconcile with recent in vivo observations. In a DPB model of lung infection, pulmonary
inflammation induced by a P. aeruginosa mutant strain with reduced active elastase was
compared with that of a wild type strain. Although both strains survived equally well, a
relatively more intense infiltration of mononuclear inflammatory cells occurred in the
bronchi of the wild type P. aeruginosa treated animals on day 90 post-incubation (WitkoSarsat et al., 1999). Similarly, in a rat air pouch model of acute infection, enzymatically
active PE significantly increased the host inflammatory response as evidenced by a
higher exudate volume and an increase in the number of neutrophils and the IL-8
concentration (Kida et al., 2007). The mechanisms of PE-induced inflammatory
responses in these models; however, are not yet clear.
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In conclusion, our data suggest that PE may in part modulate lung inflammation
by enhancing IL-8 production by lung fibroblasts. This physiologic alteration may occur
via PE-induced activation of ERK1/2 and nuclear translocation of NFkB that eventually
binds the enhancer region and activates IL-8 gene expression and protein synthesis. The
observed data represent a newly recognized pathway by which lung fibroblasts can
influence local expression of IL-8 and inflammatory cell traffic within the injured lung.
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